Oprozomib (PR-047) is an Orally Active Peptide Epoxyketone Proteasome Inhibitor
Proteasome inhibition has been validated as a modality in the research of multiple myeloma and Non-Hodgkin’s lymphoma. The proteasome is a multicatalytic protease complex that is responsible for the ubiquitin-dependent…